Skip to main content
INSM
NASDAQ Life Sciences

TPIP 12-Month Data Shows Sustained 6MWD Gain, 60% NT-proBNP Drop in PAH

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$111
Mkt Cap
$23.802B
52W Low
$90.39
52W High
$212.75
52W Position info
23% above low
Off High info
48% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

INSM sits 23% above its 52-week low of $90.39.

Summary

Insmed's 12-month open-label extension data for TPIP in pulmonary arterial hypertension (PAH) showed durable efficacy and a clean safety profile. Patients continuing TPIP maintained a 55.7-meter improvement in 6-minute walk distance, while those crossing over from placebo caught up to 54.1 meters. NT-proBNP, a key biomarker of heart failure severity, dropped roughly 60% from baseline in both groups and held through Month 12. Functional class improvements were striking: about 80% of patients reached WHO Class I or II, with over 25% achieving Class I. The REVEAL Lite 2.0 risk score improved by 2.0 points in the continued group, and roughly 65% of patients hit Refined Low Risk status. Safety was consistent with prior data—treatment-emergent adverse events in 89% of patients, serious events in 18.7%, and four deaths deemed unrelated to treatment. This is the first detailed look at long-term TPIP outcomes and materially de-risks the program ahead of a potential regulatory filing. The data follows the 8-K filed this morning and supports TPIP's differentiation in a market with limited oral prostacyclin options.

At the time of this announcement, INSM was trading at $111.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $23.8B. The 52-week trading range was $90.39 to $212.75. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

INSM - Latest Insights

INSM
Oct 30, 2026, 3:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $110.91
Real-time Price: $123.00 info
Change: +$12.09 (+11%) info
Market Cap: $26.957B info
INSM
Oct 29, 2026, 12:51 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $110.63
Real-time Price: $123.00 info
Change: +$12.37 (+11%) info
Market Cap: $26.957B info
INSM
Oct 29, 2026, 7:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $98.77
Real-time Price: $123.00 info
Change: +$24.23 (+25%) info
Market Cap: $26.957B info
INSM
Oct 29, 2026, 7:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $98.77
Real-time Price: $123.00 info
Change: +$24.23 (+25%) info
Market Cap: $26.957B info
INSM
Oct 15, 2026, 8:54 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $96.60
Real-time Price: $123.00 info
Change: +$26.40 (+27%) info
Market Cap: $26.957B info